|
1
|
Calvo D and Vega MA: Identification,
primary structure, and distribution of CLA-1, a novel member of the
CD36/LIMPII gene family. J Biol Chem. 268:2599–18935. 1993.
|
|
2
|
Acton S, Rigotti A, Landschulz KT, Xu S,
Hobbs HH and Krieger M: Identification of scavenger receptor SR-BI
as a high density lipoprotein receptor. Science. 271:518–520. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shen WJ, Azhar S and Kraemer FB: SR-B1: A
unique multifunctional receptor for cholesterol influx and efflux.
Annu Rev Physiol. 80:95–116. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shen WJ, Asthana S, Kraemer FB and Azhar
S: Scavenger receptor B type 1: Expression, molecular regulation,
and cholesterol transport function. J Lipid Res. 59:1114–1131.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shen WJ, Hu J, Hu Z, Kraemer FB and Azhar
S: Scavenger receptor class B type I (SR-BI): A versatile receptor
with multiple functions and actions. Metabolism. 63:875–886. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hoekstra M: SR-BI as target in
atherosclerosis and cardiovascular disease-A comprehensive
appraisal of the cellular functions of SR-BI in physiology and
disease. Atherosclerosis. 258:153–161. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kraemer FB, Shen WJ, Harada K, Patel S,
Osuga J, Ishibashi S and Azhar S: Hormone-sensitive lipase is
required for high-density lipoprotein cholesteryl ester-supported
adrenal steroidogenesis. Mol Endocrinol. 18:549–557. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Prospective Studies Collaboration,
Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey
J, Qizilbash N, Peto R and Collins R: Blood cholesterol and
vascular mortality by age, sex, and blood pressure: A meta-analysis
of individual data from 61 prospective studies with 55,000 vascular
deaths. Lancet. 370:1829–1839. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Phillips MC: Molecular mechanisms of
cellular cholesterol efflux. J Biol Chem. 289:24020–24029. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ji Y, Wang N, Ramakrishnan R, Sehayek E,
Huszar D, Breslow JL and Tall AR: Hepatic scavenger receptor BI
promotes rapid clearance of high density lipoprotein free
cholesterol and its transport into bile. J Biol Chem.
274:33398–33402. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brundert M, Ewert A, Heeren J, Behrendt B,
Ramakrishnan R, Greten H, Merkel M and Rinninger F: Scavenger
receptor class B type I mediates the selective uptake of
high-density lipoprotein-associated cholesteryl ester by the liver
in mice. Arterioscler Thromb Vasc Biol. 25:143–148. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Acton SL, Scherer PE, Lodish HF and
Krieger M: Expression cloning of SR-BI, a CD36-related class B
scavenger receptor. J Biol Chem. 269:21003–21009. 1994.PubMed/NCBI
|
|
13
|
Trigatti BL: SR-B1 and PDZK1: Partners in
HDL regulation. Curr Opin Lipidol. 28:201–208. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang L, Chambliss KL, Gao X, Yuhanna IS,
Behling-Kelly E, Bergaya S, Ahmed M, Michaely P, Luby-Phelps K,
Darehshouri A, et al: SR-B1 drives endothelial cell LDL
transcytosis via DOCK4 to promote atherosclerosis. Nature.
569:565–569. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Neculai D, Schwake M, Ravichandran M,
Zunke F, Collins RF, Peters J, Neculai M, Plumb J, Loppnau P,
Pizarro JC, et al: Structure of LIMP-2 provides functional insights
with implications for SR-BI and CD36. Nature. 504:172–176. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Linton MF, Tao H, Linton EF and Yancey PG:
SR-BI: A multifunctional receptor in cholesterol homeostasis and
atherosclerosis. Trends Endocrinol Metab. 28:461–472. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sahebi R, Hassanian SM, Ghayour-Mobarhan
M, Farrokhi E, Rezayi M, Samadi S, Bahramian S, Ferns GA and Avan
A: Scavenger receptor Class B type I as a potential risk
stratification biomarker and therapeutic target in cardiovascular
disease. J Cell Physiol. 234:16925–16932. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Van Eck M, Twisk J, Hoekstra M, Van Rij
BT, Van der Lans CA, Bos IS, Kruijt JK, Kuipers F and Van Berkel
TJ: Differential effects of scavenger receptor BI deficiency on
lipid metabolism in cells of the arterial wall and in the liver. J
Biol Chem. 278:23699–23705. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Braun A, Trigatti BL, Post MJ, Sato K,
Simons M, Edelberg JM, Rosenberg RD, Schrenzel M and Krieger M:
Loss of SR-BI expression leads to the early onset of occlusive
atherosclerotic coronary artery disease, spontaneous myocardial
infarctions, severe cardiac dysfunction, and premature death in
apolipoprotein E-deficient mice. Circ Res. 90:270–276. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Braun A, Zhang S, Miettinen HE, Ebrahim S,
Holm TM, Vasile E, Post MJ, Yoerger DM, Picard MH, Krieger JL, et
al: Probucol prevents early coronary heart disease and death in the
high-density lipoprotein receptor SR-BI/apolipoprotein E double
knockout mouse. Proc Natl Acad Sci USA. 100:7283–7288. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fuller M, Dadoo O, Serkis V, Abutouk D,
MacDonald M, Dhingani N, Macri J, Igdoura SA and Trigatti BL: The
effects of diet on occlusive coronary artery atherosclerosis and
myocardial infarction in scavenger receptor class B, type
1/low-density lipoprotein receptor double knockout mice.
Arterioscler Thromb Vasc Biol. 34:2394–2403. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Leiva A, Verdejo H, Benitez ML, Martinez
A, Busso D and Rigotti A: Mechanisms regulating hepatic SR-BI
expression and their impact on HDL metabolism. Atherosclerosis.
217:299–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kozarsky KF, Donahee MH, Glick JM, Krieger
M and Rader DJ: Gene transfer and hepatic overexpression of the HDL
receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL
receptor-deficient mouse. Arterioscler Thromb Vasc Biol.
20:721–727. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huby T, Doucet C, Dachet C, Ouzilleau B,
Ueda Y, Afzal V, Rubin E, Chapman MJ and Lesnik P: Knockdown
expression and hepatic deficiency reveal an atheroprotective role
for SR-BI in liver and peripheral tissues. J Clin Invest.
116:2767–2776. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Van Eck M, Hoekstra M, Out R, Bos IS,
Kruijt JK, Hildebrand RB and Van Berkel TJ: Scavenger receptor BI
facilitates the metabolism of VLDL lipoproteins in vivo. J Lipid
Res. 49:136–146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang XP, Amar MJ, Vaisman B, Bocharov AV,
Vishnyakova TG, Freeman LA, Kurlander RJ, Patterson AP, Becker LC
and Remaley AT: Scavenger receptor-BI is a receptor for
lipoprotein(a). J Lipid Res. 54:2450–2457. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang X, Sethi A, Yanek LR, Knapper C,
Nordestgaard BG, Tybjærg-Hansen A, Becker DM, Mathias RA, Remaley
AT and Becker LC: SCARB1 gene variants are associated with the
phenotype of combined high high-density lipoprotein cholesterol and
high lipoprotein (a). Circ Cardiovasc Genet. 9:408–418. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Saddar S, Mineo C and Shaul PW: Signaling
by the high-affinity HDL receptor scavenger receptor B type I.
Arterioscler Thromb Vasc Biol. 30:144–150. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rohrer L, Ohnsorg PM, Lehner M, Landolt F,
Rinninger F and von Eckardstein A: High-density lipoprotein
transport through aortic endothelial cells involves scavenger
receptor BI and ATP-binding cassette transporter G1. Circ Res.
104:1142–1150. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Armstrong SM, Sugiyama MG, Fung KY, Gao Y,
Wang C, Levy AS, Azizi P, Roufaiel M, Zhu SN, Neculai D, et al: A
novel assay uncovers an unexpected role for SR-BI in LDL
transcytosis. Cardiovasc Res. 108:268–277. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Seetharam D, Mineo C, Gormley AK, Gibson
LL, Vongpatanasin W, Chambliss KL, Hahner LD, Cummings ML, Kitchens
RL, Marcel YL, et al: High-density lipoprotein promotes endothelial
cell migration and reendothelialization via scavenger receptor-B
type I. Circ Res. 98:63–72. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mineo C and Shaul PW: Role of high-density
lipoprotein and scavenger receptor B type I in the promotion of
endothelial repair. Trends Cardiovasc Med. 17:156–161. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu W, Saddar S, Seetharam D, Chambliss
KL, Longoria C, Silver DL, Yuhanna IS, Shaul PW and Mineo C: The
scavenger receptor class B type I adaptor protein PDZK1 maintains
endothelial monolayer integrity. Circ Res. 102:480–487. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vaisman BL, Vishnyakova TG, Freeman LA,
Amar MJ, Demosky SJ, Liu C, Stonik JA, Sampson ML, Pryor M,
Bocharov AV, et al: Endothelial expression of scavenger receptor
class B, type I protects against development of atherosclerosis in
mice. Biomed Res Int. 2015:6071202015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fung KY, Wang C, Nyegaard S, Heit B, Fairn
GD and Lee WL: SR-BI mediated transcytosis of HDL in brain
microvascular endothelial cells is independent of caveolin,
clathrin, and PDZK1. Front Physiol. 8:8412017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gadea G and Blangy A: Dock-family exchange
factors in cell migration and disease. Eur J Cell Biol. 93:466–477.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fluiter K, van der Westhuijzen DR and van
Berkel TJ: In vivo regulation of scavenger receptor BI and the
selective uptake of high density lipoprotein cholesteryl esters in
rat liver parenchymal and kupffer cells. J Biol Chem.
273:8434–8438. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yancey PG, de la Llera-Moya M, Swarnakar
S, Monzo P, Klein SM, Connelly MA, Johnson WJ, Williams DL and
Rothblat GH: High density lipoprotein phospholipid composition is a
major determinant of the bi-directional flux and net movement of
cellular free cholesterol mediated by scavenger receptor BI. J Biol
Chem. 275:36596–36604. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Matveev S, van der Westhuyzen DR and Smart
EJ: Co-expression of scavenger receptor-BI and caveolin-1 is
associated with enhanced selective cholesteryl ester uptake in
THP-1 macrophages. J Lipid Res. 40:1647–1654. 1999.PubMed/NCBI
|
|
40
|
Ji Y, Jian B, Wang N, Sun Y, Moya ML,
Phillips MC, Rothblat GH, Swaney JB and Tall AR: Scavenger receptor
BI promotes high density lipoprotein-mediated cellular cholesterol
efflux. J Biol Chem. 272:20982–20985. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mineo C: Lipoprotein receptor signalling
in atherosclerosis. Cardiovasc Res. 116:1254–1274. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Song GJ, Kim SM, Park KH, Kim J, Choi I
and Cho KH: SR-BI mediates high density lipoprotein (HDL)-induced
anti-inflammatory effect in macrophages. Biochem Biophys Res
Commun. 457:112–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tao H, Yancey PG, Babaev VR, Blakemore JL,
Zhang Y, Ding L, Fazio S and Linton MF: Macrophage SR-BI mediates
efferocytosis via Src/PI3K/Rac1 signaling and reduces
atherosclerotic lesion necrosis. J Lipid Res. 56:1449–1460. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Karackattu SL, Picard MH and Krieger M:
Lymphocytes are not required for the rapid onset of coronary heart
disease in scavenger receptor class B type I/apolipoprotein E
double knockout mice. Arterioscler Thromb Vasc Biol. 25:803–808.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Van Eck M, Bos IS, Hildebrand RB, Van Rij
BT and Van Berkel TJ: Dual role for scavenger receptor class B,
type I on bone marrow-derived cells in atherosclerotic lesion
development. Am J Pathol. 165:785–794. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pei Y, Chen X, Aboutouk D, Fuller MT,
Dadoo O, Yu P, White EJ, Igdoura SA and Trigatti BL: SR-BI in bone
marrow derived cells protects mice from diet induced coronary
artery atherosclerosis and myocardial infarction. PLoS One.
8:e724922013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Badeau RM, Metso J, Wähälä K, Tikkanen MJ
and Jauhiainen M: Human macrophage cholesterol efflux potential is
enhanced by HDL-associated 17beta-estradiol fatty acyl esters. J
Steroid Biochem Mol Biol. 116:44–49. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Vergeer M, Korporaal SJ, Franssen R, Meurs
I, Out R, Hovingh GK, Hoekstra M, Sierts JA, Dallinga-Thie GM,
Motazacker MM, et al: Genetic variant of the scavenger receptor BI
in humans. N Engl J Med. 364:136–145. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lindemann S, Krämer B, Daub K, Stellos K
and Gawaz M: Molecular pathways used by platelets to initiate and
accelerate atherogenesis. Curr Opin Lipidol. 18:566–573. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Olas B: Biochemistry of blood platelet
activation and the beneficial role of plant oils in cardiovascular
diseases. Adv Clin Chem. 95:219–243. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Valiyaveettil M, Kar N, Ashraf MZ, Byzova
TV, Febbraio M and Podrez EA: Oxidized high-density lipoprotein
inhibits platelet activation and aggregation via scavenger receptor
BI. Blood. 111:1962–1971. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Brodde MF, Korporaal SJ, Herminghaus G,
Fobker M, Van Berkel TJ, Tietge UJ, Robenek H, Van Eck M, Kehrel BE
and Nofer JR: Native high-density lipoproteins inhibit platelet
activation via scavenger receptor BI: Role of negatively charged
phospholipids. Atherosclerosis. 215:374–382. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Brill A, Yesilaltay A, De Meyer SF,
Kisucka J, Fuchs TA, Kocher O, Krieger M and Wagner DD:
Extrahepatic high-density lipoprotein receptor SR-BI and apoA-I
protect against deep vein thrombosis in mice. Arterioscler Thromb
Vasc Biol. 32:1841–1847. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Korporaal SJ, Meurs I, Hauer AD,
Hildebrand RB, Hoekstra M, Cate HT, Praticò D, Akkerman JW, Van
Berkel TJ, Kuiper J and Van Eck M: Deletion of the high-density
lipoprotein receptor scavenger receptor BI in mice modulates
thrombosis susceptibility and indirectly affects platelet function
by elevation of plasma free cholesterol. Arterioscler Thromb Vasc
Biol. 31:34–42. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ouweneel AB, Hoekstra M, van der Wel EJ,
Schaftenaar FH, Snip OSC, Hassan J, Korporaal SJA and Van Eck M:
Hypercholesterolemia impairs megakaryopoiesis and platelet
production in scavenger receptor BI knockout mice. Atherosclerosis.
282:176–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
